Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson's disease.

Autor: Ben Bashat, Dafna, Thaler, Avner, Lerman Shacham, Hedva, Even-Sapir, Einat, Hutchison, Matthew, Evans, Karleyton C., Orr-Urterger, Avi, Cedarbaum, Jesse M., Droby, Amgad, Giladi, Nir, Mirelman, Anat, Artzi, Moran

Publikováno v: NPJ Parkinson's Disease; 10/21/2022, Vol. 8 Issue 1, p1-8, 8p

Neuromelanin and T 2 *-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson's disease.

Autor: Ben Bashat D; Sagol Brain Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. dafnab@tlvmc.gov.il.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. dafnab@tlvmc.gov.il.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. dafnab@tlvmc.gov.il., Thaler A; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Laboratory of Early Markers Of Neurodegeneration (LEMON), Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Lerman Shacham H; Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel., Even-Sapir E; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel., Hutchison M; Biogen Inc., Cambridge, MA, USA., Evans KC; Biogen Inc., Cambridge, MA, USA., Orr-Urterger A; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Genomic Research Laboratory for Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Cedarbaum JM; Coeruleus Clinical Sciences LLC, Woodbridge, CT, USA.; Yale University School of Medicine, New Haven, CT, USA., Droby A; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Laboratory of Early Markers Of Neurodegeneration (LEMON), Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Giladi N; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Laboratory of Early Markers Of Neurodegeneration (LEMON), Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Mirelman A; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Laboratory of Early Markers Of Neurodegeneration (LEMON), Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Artzi M; Sagol Brain Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.

Publikováno v: NPJ Parkinson's disease [NPJ Parkinsons Dis] 2022 Oct 21; Vol. 8 (1), pp. 139. Date of Electronic Publication: 2022 Oct 21.